Heßling, K., Brand, C., Schwöppe, C., Gerwing, M., Pavelka, S., Berdel, A. F., . . . Schliemann, C. (2026). Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: Translational data, clinical safety and efficacy. Scientific reports, 16, . https://doi.org/10.1038/s41598-026-40362-4
Cita Chicago Style (17a ed.)Heßling, Kathrin, et al. "Trabectedin Plus CD13-targeted Tissue Factor TTF-NGR Against Advanced Relapsed or Refractory Soft Tissue Sarcoma: Translational Data, Clinical Safety and Efficacy." Scientific Reports 16 (2026). https://doi.org/10.1038/s41598-026-40362-4.
Cita MLA (9a ed.)Heßling, Kathrin, et al. "Trabectedin Plus CD13-targeted Tissue Factor TTF-NGR Against Advanced Relapsed or Refractory Soft Tissue Sarcoma: Translational Data, Clinical Safety and Efficacy." Scientific Reports, vol. 16, 2026, https://doi.org/10.1038/s41598-026-40362-4.